Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles

• Main Authors: Khan MM, Madni A, Tahir N, Parveen F, Khan S, Jan N, Ali A, Abdurrahim M, Farooq U, Khan MI
• Format: Article
• Language: English
• Published: Dove Medical Press 2020-03-01
• Series: International Journal of Nanomedicine
• Subjects: co-delivery; chemosensitization; curcumin; cisplatin; enhanced therapeutic output
• Online Access: https://www.dovepress.com/co-delivery-of-curcumin-and-cisplatin-to-enhance-cytotoxicity-of-cispl-peer-reviewed-article-IJN

Muhammad Muzamil Khan,1 Asadullah Madni,1 Nayab Tahir,2 Farzana Parveen,1 Safiullah Khan,1 Nasrullah Jan,1 Ahsan Ali,1 Muhammad Abdurrahim,1 Umar Farooq,3 Muhammad Imran Khan4 1Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan; 2College of Pharmacy, University of Sargodha, Sargodha, Pakistan; 3Department of Pharmacy, Government College University Faisalabad, Faisalabad, Pakistan; 4Faculty of Pharmacy, Riphah International University, Lahore, PakistanCorrespondence: Muhammad Muzamil KhanThe Islamia University of Bahawalpur, Bahawalpur, Punjab 63100, PakistanEmail [e-mail] MadniDepartment of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Punjab 63100, PakistanTel [phone]Email [e-mail]: Lipid-polymer hybrid nanoparticles (LPHNP) are suitable for co-delivery of hydrophilic and lipophilic drugs. The structural advantages of polymers and biomimetic properties of lipids enable higher encapsulation of drugs and controlled release profile. Lipid-polymer hybrid nanoparticles have been prepared for co-delivery of curcumin and cisplatin for enhanced cytotoxicity against ovarian cancer.Material and Methods: Chitosan, cisplatin, curcumin, Lipoid S75 were selected as structural components and ionic gelation method was used for preparation of LPHNPs. Nanoparticles were formed via ionic interaction of positively charged chitosan and negatively charged lipid.Results: The optimized nanoparticles were of 225 nm with cationic charge. The encapsulation efficiency was greater than 80% with good drug loading. The drug release profile showed controlled release behavior of both curcumin and cisplatin simultaneously and the absence of burst release. The in vitro therapeutic efficacy and cellular association was evaluated using A2780 ovarian cell lines. To further investigate therapeutic efficacy, we developed 3D spheroids as tumor model to mimic the in vivo conditions. The cytotoxicity and uptake of co-loaded LPHNPs were evaluated on 3D spheroids and results indicated increased chemosensitization and enhanced therapeutic efficacy of co-loaded LPHNPs.Conclusion: Lipid-polymer hybrid nanoparticles could be a suitable platform for co-delivery of curcumin and cisplatin for enhanced cytotoxic effect on ovarian cell lines.Keywords: co-delivery, chemosensitization, curcumin, cisplatin, enhanced therapeutic output